Literature DB >> 29959045

Is MED13L-related intellectual disability a recognizable syndrome?

Pernille Mathiesen Tørring1, Martin Jakob Larsen2, Charlotte Brasch-Andersen2, Lotte Nylandsted Krogh2, Maria Kibæk3, Lone Laulund3, Niels Illum3, Ulrike Dunkhase-Heinl4, Antje Wiesener5, Bernt Popp5, Giuseppe Marangi6, Tina Duelund Hjortshøj7, Jakob Ek7, Ida Vogel8, Naja Becher8, Laura Roos7, Marcella Zollino6, Christina Ringmann Fagerberg2.   

Abstract

INTRODUCTION: MED13L-related intellectual disability is characterized by moderate intellectual disability (ID), speech impairment, and dysmorphic facial features. We present 8 patients with MED13L-related intellectual disability and review the literature for phenotypical and genetic aspects of previously described patients.
MATERIALS AND METHODS: In the search for genetic aberrations in individuals with ID, two of the patients were identified by chromosomal microarray analysis, and five by exome sequencing. One of the individuals, suspected of MED13L-related intellectual disability, based on clinical features, was identified by Sanger sequencing.
RESULTS: All 8 individuals had de novo MED13L aberrations, including two intragenic microdeletions, two frameshift, three nonsense variants, and one missense variant. Phenotypically, they all had intellectual disability, speech and motor delay, and features of the mouth (open mouth appearance, macroglossia, and/or macrostomia). Two individuals were diagnosed with autism, and one had autistic features. One had complex congenital heart defect, and one had persistent foramen ovale. The literature was reviewed with respect to clinical and dysmorphic features, and genetic aberrations.
CONCLUSIONS: Even if most clinical features of MED13L-related intellectual disability are rather non-specific, the syndrome may be suspected in some individuals based on the association of developmental delay, speech impairment, bulbous nasal tip, and macroglossia, macrostomia, or open mouth appearance.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Developmental delay; Intellectual disability; MED13L; MED13L haploinsufficiency syndrome; MED13L-related intellectual disability

Mesh:

Substances:

Year:  2018        PMID: 29959045     DOI: 10.1016/j.ejmg.2018.06.014

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  8 in total

1.  Co-occurring medical conditions among individuals with ASD-associated disruptive mutations.

Authors:  Evangeline C Kurtz-Nelson; Jennifer S Beighley; Caitlin M Hudac; Jennifer Gerdts; Arianne S Wallace; Kendra Hoekzema; Evan E Eichler; Raphael A Bernier
Journal:  Child Health Care       Date:  2020-03-17

2.  Mutations in Mediator Complex Genes CDK8, MED12, MED13, and MEDL13 Mediate Overlapping Developmental Syndromes.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2019-08-16

Review 3.  Transcription Pause and Escape in Neurodevelopmental Disorders.

Authors:  Kristel N Eigenhuis; Hedda B Somsen; Debbie L C van den Berg
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

Review 4.  MED12-Related (Neuro)Developmental Disorders: A Question of Causality.

Authors:  Stijn van de Plassche; Arjan Pm de Brouwer
Journal:  Genes (Basel)       Date:  2021-04-28       Impact factor: 4.096

Review 5.  Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability.

Authors:  Zhi Yi; Ying Zhang; Zhenfeng Song; Hong Pan; Chengqing Yang; Fei Li; Jiao Xue; Zhenghai Qu
Journal:  Ital J Pediatr       Date:  2020-07-09       Impact factor: 2.638

6.  MED13L-related intellectual disability due to paternal germinal mosaicism.

Authors:  Beáta Bessenyei; István Balogh; Attila Mokánszki; Anikó Ujfalusi; Rolph Pfundt; Katalin Szakszon
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-01-10

7.  Aberrant cyclin C nuclear release induces mitochondrial fragmentation and dysfunction in MED13L syndrome fibroblasts.

Authors:  Kai-Ti Chang; Jan Jezek; Alicia N Campbell; David C Stieg; Zachary A Kiss; Kevin Kemper; Ping Jiang; Hyung-Ok Lee; Warren D Kruger; Peter M van Hasselt; Randy Strich
Journal:  iScience       Date:  2022-01-30

Review 8.  Potential roles of mediator Complex Subunit 13 in Cardiac Diseases.

Authors:  Wenqian Zhou; He Cai; Jia Li; He Xu; Xiang Wang; Hongbo Men; Yang Zheng; Lu Cai
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.